The Korea Disease Control and Prevention Agency (KDCA) announced its 2026 work plan, focusing on preparing for new infectious disease disasters, protecting the healthy daily lives of citizens, and proactively responding to future changes such as climate change.
In 2025, KDCA was recognized as having the world’s highest level of national health security capabilities by the WHO Joint External Evaluation and developed and commercialized the world’s first recombinant protein anthrax vaccine.
In 2026, KDCA plans to implement 10 key initiatives, including enhancing the infectious disease crisis response system, localizing infectious disease vaccines and treatments, and diversifying infectious disease diagnostic infrastructure.